Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis

Journal of the American Academy of Dermatology

Volumn 59, Issue 2, 2008, Pages 352-353

  Lee, Haur Yueh ^a   Pang, Shiu Ming ^a   Thamotharampillai, Thirumoorthy ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; OXIPURINOL;

ALLOPURINOL INDUCED STEVENS JOHNSON SYNDROME; ALLOPURINOL INDUCED TOXIC EPIDERMAL NECROLYSIS; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; GENETIC MARKER; HUMAN; HYPERSENSITIVITY; KIDNEY FAILURE; LETTER; PHARMACOGENETICS; PRIORITY JOURNAL; RISK ASSESSMENT; TIME SERIES ANALYSIS; TREATMENT INDICATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALLOPURINOL; EPIDERMAL NECROLYSIS, TOXIC; GOUT SUPPRESSANTS; HUMANS; STEVENS-JOHNSON SYNDROME;

EID: 47049127171     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.02.021     Document Type: Letter

References (5)

1. Halevy S., Ghislain P.D., Mockenhaupt M., Fagot J.P., Bouwes Bavinck J.N., Sidoroff A., et al. Allopurinol is the most common Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 58 (2008) 25-32
2. Lee H.Y., Ariyasinghe J.T., and Thirumoorthy T. Allopurinol hypersensitivity syndrome-A preventable severe cutaneous adverse reaction?. Singapore Med J 49 (2008) 384-387
3. Hande K.R., Noone R.M., and Stone W.J. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med 76 (1984) 47-56
4. *5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 102 (2005) 4134-4139
5. *5701 screening for hypersensitivity to abacavir. N Engl J Med 358 (2008) 568-579